Strengthening Primary Care by Changing How We Pay For It
Provider Payment Incentives
Strengthening Primary Care by Changing How We Pay For It
Meaningful Reforms to Medicare Are Needed Now to Sustain the Program for Future Generations
Medicare Sustainability
Meaningful Reforms to Medicare Are Needed Now to Sustain the Program for Future Generations
Clinical Trials
Using the Master Protocol to Obtain Better Clinical Trials for Research
AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan
Drug Prices
AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan
Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong
Drug Prices
Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong
Improving Payment for Primary Care: The Foundation of a High-Quality, Affordable Health Care System
Provider Payment Incentives
Improving Payment for Primary Care: The Foundation of a High-Quality, Affordable Health Care System
Successes & Opportunities in Patient-First Care
Provider Payment Incentives
Successes & Opportunities in Patient-First Care
Medicare Sustainability
AV Submits Letter Addressing Overpayments in Medicare Advantage
Drug Prices
What a Bipartisan State of the Union Looks Like
Op-Ed
Same Service, Same Price
New Chart Shows State-Level Impacts of Site Neutrality
Commercial Sector Prices
AV Submits Letter on the Proposed Rule on Operations of the No Surprises Act’s Independent Dispute Resolution Process
Clinical Trials
AV Responds to HELP Committee Request for Information on Gene Therapies
Medicare-Medicaid Integration
AV Submits Letter on Transparency and Accountability in Medicare Advantage
Commercial Sector Prices
Paying a Site-Neutral Rate for Off-Campus Outpatient Departments Could Save Billions
State Policy Win Snapshot: Texas and Connecticut Fight Anti-Competitive Hospital Practices
Commercial Sector Prices
State Policy Win Snapshot: Texas and Connecticut Fight Anti-Competitive Hospital Practices
State Policy Win Snapshot
Clinical Trials
AV Submits Letter on Controlled Clinical Investigation and Confirmatory Evidence
A Year in Policy Wins
Drug Prices
A Year in Policy Wins
23 Stories of Transformative Policymaking from 2023
Policing
23 Stories of Transformative Policymaking from 2023
Year in Review
Drug Prices
AV Submits Letter on Excise Tax on Designated Drugs
In Louisiana, a Subscription-Based Model Is Changing Hepatitis C Treatment
Drug Prices
In Louisiana, a Subscription-Based Model Is Changing Hepatitis C Treatment
Dual Eligible Americans Need Support During Medicare Open Enrollment
Medicare-Medicaid Integration
Dual Eligible Americans Need Support During Medicare Open Enrollment
Site-Neutral Payments Could Mean Big Savings for Patients With Chronic Conditions
Commercial Sector Prices
Site-Neutral Payments Could Mean Big Savings for Patients With Chronic Conditions
How a Broken Patent System Contributes to Unaffordable Prescription Drugs
Drug Prices
How a Broken Patent System Contributes to Unaffordable Prescription Drugs
New Opportunity for States to Improve Health Care and Slow Cost Growth
Provider Payment Incentives
New Opportunity for States to Improve Health Care and Slow Cost Growth
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
